Actinogen Medical Limited
ATGGF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | -$0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | -100% | 892.5% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 100% | – | 100% | 76.7% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -124.1% | – | -16% | -1,346.8% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -119.6% | – | -16.5% | -1,271.3% |
| EPS Diluted | -0.002 | -0.28 | -0.001 | -0.005 |
| % Growth | 99.2% | -39,900% | 85.7% | – |
| Operating Cash Flow | -$0 | $0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | $0 | -$0 | -$0 |